|
Free Research Articles
Citations 121-130 of 789 total displayed.
|
Past content
(since May 2004):
|
How I treat patients with myelodysplastic syndromes
- Richard M. Stone
Blood 2009; 113: 6296-6303.
[Full text]
[PDF]
IL-7 administration drives T cell–cycle entry and expansion in HIV-1 infection
- Irini Sereti, Richard M. Dunham, John Spritzler, Evgenia Aga, Michael A. Proschan, Kathy Medvik, Catherine A. Battaglia, Alan L. Landay, Savita Pahwa, Margaret A. Fischl, David M. Asmuth, Allan R. Tenorio, John D. Altman, Lawrence Fox, Susan Moir, Angela Malaspina, Michel Morre, Renaud Buffet, Guido Silvestri, and Michael M. Lederman, for the ACTG 5214 Study Team
Blood 2009; 113: 6304-6314.
[Abstract]
[Full text]
[PDF]
Delayed achievement of cytogenetic and molecular response is associated with increased risk of progression among patients with chronic myeloid leukemia in early chronic phase receiving high-dose or standard-dose imatinib therapy
- Alfonso Quintás-Cardama, Hagop Kantarjian, Dan Jones, Jianqin Shan, Gautam Borthakur, Deborah Thomas, Steven Kornblau, Susan O'Brien, and Jorge Cortes
Blood 2009; 113: 6315-6321.
[Abstract]
[Full text]
[PDF]
Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up
- Hagop Kantarjian, Jorge Cortes, Dong-Wook Kim, Pedro Dorlhiac-Llacer, Ricardo Pasquini, John DiPersio, Martin C. Müller, Jerald P. Radich, H. Jean Khoury, Nina Khoroshko, M. Brigid Bradley-Garelik, Chao Zhu, and Martin S. Tallman
Blood 2009; 113: 6322-6329.
[Abstract]
[Full text]
[PDF]
C-terminal ADAMTS-18 fragment induces oxidative platelet fragmentation, dissolves platelet aggregates, and protects against carotid artery occlusion and cerebral stroke
- Zongdong Li, Michael A. Nardi, Yong-Sheng Li, Wei Zhang, Ruimin Pan, Suying Dang, Herman Yee, David Quartermain, Saran Jonas, and Simon Karpatkin
Blood 2009; 113: 6051-6060.
[Abstract]
[Full text]
[PDF]
Therapeutic targeting of MLL
- Michaela Liedtke and Michael L. Cleary
Blood 2009; 113: 6061-6068.
[Abstract]
[Full text]
[PDF]
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma
- Kieron Dunleavy, Stefania Pittaluga, Myron S. Czuczman, Sandeep S. Dave, George Wright, Nicole Grant, Margaret Shovlin, Elaine S. Jaffe, John E. Janik, Louis M. Staudt, and Wyndham H. Wilson
Blood 2009; 113: 6069-6076.
[Abstract]
[Full text]
[PDF]
Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study
- Kjeld Schmiegelow, Ibrahim Al-Modhwahi, Mette Klarskov Andersen, Mikael Behrendtz, Erik Forestier, Henrik Hasle, Mats Heyman, Jon Kristinsson, Jacob Nersting, Randi Nygaard, Anne Louise Svendsen, Kim Vettenranta, and Richard Weinshilboum, for the Nordic Society for Paediatric Haematology and Oncology
Blood 2009; 113: 6077-6084.
[Abstract]
[Full text]
[PDF]
Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms
- Francis H. Grand, Claire E. Hidalgo-Curtis, Thomas Ernst, Katerina Zoi, Christine Zoi, Carolann McGuire, Sebastian Kreil, Amy Jones, Joannah Score, Georgia Metzgeroth, David Oscier, Andrew Hall, Christian Brandts, Hubert Serve, Andreas Reiter, Andrew J. Chase, and Nicholas C. P. Cross
Blood 2009; 113: 6182-6192.
[Abstract]
[Full text]
[PDF]
How we treat cytomegalovirus in hematopoietic cell transplant recipients
- Michael Boeckh and Per Ljungman
Blood 2009; 113: 5711-5719.
[Abstract]
[Full text]
[PDF]
|
|
